Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.21174 | 49 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.1215 | 48 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.33144 | 54 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 8.7844 | 95 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.03301 | 46 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.78227 | 62 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.19561 | 48 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.45462 | 57 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.31412 | 54 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.06151 | 46 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.10483 | 47 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.25533 | 53 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.12211 | 47 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.09952 | 47 |